Descriptor English: | 16,16-Dimethylprostaglandin E2 | ||||
Descriptor Spanish: |
16,16-Dimetilprostaglandina E2
| ||||
Descriptor Portuguese: | 16,16-Dimetilprostaglandina E2 | ||||
Descriptor French: | Diméthyl-16,16 prostaglandine E2 | ||||
Entry term(s): |
16,16 Dimethyl PGE2 16,16 Dimethylprostaglandin E2 16,16-Dimethyl-PGE2 E2, 16,16-Dimethylprostaglandin |
||||
Tree number(s): |
D10.251.355.255.550.775.450.300 D23.469.050.175.725.775.450.300 D23.469.700.660.200 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015064 | ||||
Scope note: | A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and growth of experimental tumors. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Anti-Ulcer Agents |
||||
Registry Number: | M790V82VAC | ||||
CAS Type 1 Name: | Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-16,16-dimethyl-9-oxo-, (5Z,11alpha,13E,15R)- | ||||
Previous Indexing: |
Prostaglandins (1966-1974) Prostaglandins E (1975-1977) Prostaglandins E, Synthetic (1978-1979) Prostaglandins, Synthetic (1977) |
||||
Public MeSH Note: | 91; was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; DIMETHYLDINOPROSTONE & 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER were see 16,16-DIMETHYLPROSTAGLANDIN E2 1980-93 |
||||
Online Note: | use 16,16-DIMETHYLPROSTAGLANDIN E2 to search DIMETHYLDINOPROSTONE & 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER 1980-93 |
||||
History Note: | 91(80); was see under PROSTAGLANDINS E, SYNTHETIC 1980-90; DIMETHYLDINOPROSTONE & 16,16-DIMETHYLPROSTAGLANDIN E2 METHYL ESTER were see 16,16-DIMETHYLPROSTAGLANDIN E2 1980-93 |
||||
Entry Version: | DIMETHYLPGE2 |
||||
DeCS ID: | 4179 | ||||
Unique ID: | D015064 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1991/01/01 | ||||
Date of Entry: | 1979/05/23 | ||||
Revision Date: | 2015/06/08 |
-
-
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
16,16-Dimethylprostaglandin E2
- Preferred
Concept UI |
M0023176 |
Scope note | A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and growth of experimental tumors. |
Preferred term | 16,16-Dimethylprostaglandin E2 |
Entry term(s) |
16,16 Dimethyl PGE2 16,16 Dimethylprostaglandin E2 16,16-Dimethyl-PGE2 E2, 16,16-Dimethylprostaglandin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey